# Montelukast Sodium

NDC: 59651-329
Generic name: Montelukast Sodium
Labeler / Manufacturer: Aurobindo Pharma Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: GRANULE
Routes: ORAL
Marketing started: 20200218

FDA application: ANDA213471

## Active ingredients

- MONTELUKAST SODIUM: 4 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"59651-329"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=59651-329
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9a3bfc59-0ca6-4433-abf5-41659bfe0a8f